IGF-1 LR3: The Downstream Driver of
Growth, Repair & Regeneration
Pharmaceutical-grade IGF-1 LR3, compounded by a U.S.-licensed 503B outsourcing facility and prescribed by a licensed physician. Not research grade. Not gray market. Your consultation, supplies, and 2-day FedEx shipping are included.
IGF-1 LR3 is a long-acting analogue of Insulin-like Growth Factor 1, the primary downstream mediator through which growth hormone exerts its anabolic, regenerative, and metabolic effects on every tissue in the body.
Prescription required. Provider consultation, supplies, and shipping included.
What Is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) is a synthetic, long-acting analogue of endogenous IGF-1 — the primary anabolic hormone through which growth hormone drives its effects on muscle, bone, fat, connective tissue, and cellular repair throughout the body.
Native IGF-1 is produced primarily in the liver in response to growth hormone stimulation. It circulates bound to IGF binding proteins (IGFBPs), which regulate its availability and significantly limit its half-life and free activity. IGF-1 LR3 is engineered with a 13-amino acid extension at the N-terminus and an arginine substitution at position 3 — two modifications that dramatically reduce its binding affinity for IGFBPs. The result is a form of IGF-1 that remains biologically active in circulation for significantly longer than native IGF-1, with a half-life of approximately 20–30 hours compared to native IGF-1's half-life of minutes.
By escaping IGFBP binding, IGF-1 LR3 delivers sustained, high-potency IGF-1 receptor activation across the full range of target tissues — making it the most direct and powerful way to harness the anabolic, regenerative, and metabolic signaling of the IGF-1 axis.
IGF-1 LR3 is used in clinical and performance contexts for muscle growth and hypertrophy, tissue repair, fat metabolism, bone density, and as a comprehensive cellular regeneration intervention — particularly in patients where optimizing the full growth hormone/IGF-1 axis is a therapeutic priority.
How IGF-1 LR3 Works
IGF-1 LR3 works by binding to IGF-1 receptors (IGF1R) — a tyrosine kinase receptor expressed on virtually every cell type in the body, with particularly high density in skeletal muscle, bone, adipose tissue, liver, and the nervous system. IGF1R activation triggers two primary intracellular signaling cascades: the PI3K/Akt/mTOR pathway and the Ras/MAPK/ERK pathway.
The PI3K/Akt/mTOR pathway is the master regulator of cellular growth and protein synthesis. Activation of mTOR directly drives ribosomal protein synthesis, increases amino acid uptake into muscle cells, inhibits protein breakdown (proteolysis), and stimulates satellite cell activation — the muscle stem cells responsible for muscle fiber repair and growth. This pathway is the primary driver of IGF-1 LR3's anabolic and hypertrophic effects.
The Ras/MAPK/ERK pathway governs cellular proliferation, differentiation, and survival. Its activation by IGF-1 LR3 promotes the growth, differentiation, and regeneration of a wide range of cell types — contributing to the compound's broad tissue repair, bone, and neurological benefits.
The critical advantage of IGF-1 LR3 over native IGF-1 is duration of action. By evading IGFBP sequestration, IGF-1 LR3 maintains receptor-level activity for 20–30 hours per injection — providing the sustained signaling needed to drive meaningful anabolic and regenerative outcomes that brief native IGF-1 pulses cannot sustain.
Key Biological Pathways
IGF-1 Receptor Activation
IGF-1 LR3 binds to IGF-1 receptors across virtually all tissue types, triggering the downstream signaling cascades that drive cellular growth, repair, and metabolism.
PI3K/Akt/mTOR — Protein Synthesis & Muscle Growth
mTOR pathway activation drives ribosomal protein synthesis, amino acid uptake into muscle, satellite cell activation, and inhibition of proteolysis — the core anabolic mechanism behind IGF-1 LR3's muscle-building effects.
Ras/MAPK/ERK — Cellular Proliferation & Repair
ERK pathway activation promotes cellular proliferation, differentiation, and survival across multiple tissue types — supporting bone formation, connective tissue repair, and neurological regeneration.
IGFBP Evasion — Extended Duration of Action
The LR3 modification dramatically reduces IGFBP binding affinity, extending IGF-1 LR3's half-life to 20–30 hours — providing sustained receptor activation that native IGF-1's brief half-life cannot achieve.
Fat Metabolism — Lipolysis & Glucose Sparing
IGF-1 LR3 promotes lipolysis in adipose tissue and shifts cellular fuel utilization toward fat oxidation, contributing to improved body composition alongside its anabolic muscle effects.
Satellite Cell Activation
IGF-1 LR3 activates muscle satellite cells — the resident stem cells that repair and grow muscle fibers — directly driving hypertrophy and accelerating recovery from muscle damage.
IGF-1 LR3 Benefits
IGF-1 LR3 acts at the tissue level across the full body, producing a broad range of anabolic, regenerative, and metabolic benefits:
Muscle Growth & Hypertrophy
IGF-1 LR3 is one of the most potent anabolic compounds available for skeletal muscle. Through mTOR activation and satellite cell stimulation, it drives muscle protein synthesis, inhibits muscle protein breakdown, and promotes genuine hypertrophy — particularly in the post-training window when muscle fibers are primed for growth signals.
Accelerated Recovery & Tissue Repair
IGF-1 LR3 accelerates repair of muscle, connective tissue, bone, and cartilage at the cellular level. By driving fibroblast and satellite cell activity, it shortens recovery timelines from both training stress and injury — making it highly valued in performance and rehabilitation contexts.
Fat Loss & Body Composition
IGF-1 LR3 promotes lipolysis in adipose tissue and shifts metabolic fuel preference toward fat oxidation — contributing to fat loss alongside its anabolic muscle effects. The combination of increased lean mass and reduced fat mass produces meaningful body composition improvements over a protocol cycle.
Bone Density & Skeletal Health
IGF-1 is a primary driver of osteoblast activity and bone mineral deposition. IGF-1 LR3's sustained receptor activation supports bone formation, density maintenance, and recovery from stress fractures or bone loss — clinically relevant for athletes and aging patients at risk of osteopenia.
Connective Tissue Strength
IGF-1 LR3 drives collagen synthesis and fibroblast proliferation in tendons, ligaments, and cartilage — improving connective tissue strength and resilience alongside the muscle hypertrophy it produces. This reduces injury risk in the context of increased training loads.
Neurological Regeneration
IGF-1 receptors are expressed throughout the central and peripheral nervous system. IGF-1 LR3 supports neuronal survival, peripheral nerve repair, and neuroprotection — extending its therapeutic relevance beyond purely musculoskeletal applications.
Anti-Aging & Cellular Longevity
Declining IGF-1 is one of the most measurable hallmarks of biological aging. IGF-1 LR3 directly addresses this decline at the tissue level, supporting the cellular repair, protein synthesis, and metabolic efficiency that diminish with age — making it a meaningful component of comprehensive longevity protocols.
IGF-1 LR3 Dosage & Administration
⚕️ Dosage is determined by your prescribing provider based on your individual health profile, therapeutic goals, and clinical response. IGF-1 LR3 is a potent compound — precise dosing and provider oversight are essential. The following reflects the available formulation at VitalRx and general clinical reference information.
Subcutaneous or Intramuscular Injection
IGF-1 LR3 is administered by injection — either subcutaneously (under the skin) or intramuscularly, depending on the protocol and provider guidance. Post-workout intramuscular injection in the trained muscle group is commonly used to direct anabolic signaling to recently activated tissue. Subcutaneous injection in the abdomen is used for general systemic protocols.
IGF-1 LR3 200mcg/mL — 5mL vial
20–100mcg per injection
Once daily; 4 weeks on, 4 weeks off cycling
Effects noticed within 2–4 weeks; full benefits over a complete cycle
Protocol Notes
Cycling is strongly recommended
IGF-1 LR3 protocols are typically run in cycles of 4 weeks on followed by 4 weeks off. Continuous long-term use can lead to IGF-1 receptor downregulation, reducing efficacy over time. Cycling preserves receptor sensitivity and maximizes long-term results.
Post-workout timing
For muscle growth and hypertrophy goals, post-workout injection directs IGF-1 LR3's anabolic signaling to the muscle groups that have just been trained — where satellite cells and IGF-1 receptors are most active.
Blood glucose awareness
IGF-1 LR3 has mild insulin-like activity and can lower blood glucose, particularly at higher doses. Patients should not inject in a fasted state and should be aware of hypoglycemia risk. Your provider will advise on appropriate timing relative to meals.
Important Notes
- Cycling 4 weeks on / 4 weeks off is standard practice to maintain receptor sensitivity
- Post-workout injection into the trained muscle group is commonly used for hypertrophy protocols
- Do not inject in a fully fasted state — IGF-1 LR3 has mild insulin-like activity
- Refrigerate upon receipt and use within the timeframe on your prescription label
- Syringes and alcohol swabs are included with your order
- IGF-1 blood level monitoring is recommended throughout the protocol
- Do not adjust dose without consulting your provider
IGF-1 LR3 vs. GH Secretagogues — Different Tools, Different Targets
IGF-1 LR3 and growth hormone secretagogues like Sermorelin or CJC-1295/Ipamorelin both ultimately increase IGF-1 activity — but through fundamentally different mechanisms, with different clinical implications.
GH Secretagogues
Work upstream — stimulating the pituitary to produce more GH, which then drives hepatic IGF-1 production. Preserve natural feedback regulation. Produce physiological GH and IGF-1 elevations over weeks to months.
Best for: Long-term GH axis optimization, anti-aging protocols, sleep improvement, and patients seeking a physiologically conservative approach
IGF-1 LR3
Works downstream — acting directly at IGF-1 receptors in target tissues with high potency and extended duration. Bypasses the GH axis entirely. Produces immediate and powerful anabolic, tissue repair, and metabolic effects at the cellular level. Requires careful cycling.
Best for: Patients prioritizing maximal anabolic, tissue repair, or body composition effects — particularly athletes, post-injury recovery, or those seeking direct IGF-1 axis intervention
IGF-1 LR3 and GH secretagogues can be used in complementary protocols — secretagogues optimizing the upstream GH axis while IGF-1 LR3 amplifies downstream tissue-level effects. Your provider will advise on whether a combined approach is appropriate for your goals.
Who Is IGF-1 LR3 For?
IGF-1 LR3 may be a good fit if you are:
- Seeking one of the most potent anabolic and tissue-repair peptides available for muscle growth and body composition
- Recovering from a significant musculoskeletal injury and want to accelerate cellular repair at the tissue level
- An experienced athlete or performance patient looking to optimize the IGF-1 axis directly alongside or following a GH secretagogue protocol
- Dealing with age-related muscle loss (sarcopenia), bone density decline, or connective tissue degradation
- Working with a provider on a comprehensive anti-aging or cellular regeneration protocol and want direct IGF-1 axis intervention
- Interested in neurological repair and neuroprotection alongside the compound's musculoskeletal benefits
Not for everyone: IGF-1 LR3 is a potent compound that requires careful provider oversight. It is not appropriate for patients with active malignancy — IGF-1 receptor activation can promote the growth of existing cancer cells. It is also not recommended for patients with diabetic retinopathy or uncontrolled diabetes due to its insulin-like activity. Your provider will review your full health history before prescribing.
IGF-1 LR3 Pricing at VitalRx
All prices below are retail. Your async provider consultation is included with every order. Syringes and alcohol swabs are included. Shipping via FedEx Standard Overnight is $15.
IGF-1 LR3 200mcg/mL — 5mL Injectable
Subcutaneous or Intramuscular Injectable • Syringes Included
$369.00
per vial
Long-acting IGF-1 analogue for muscle growth, tissue repair, fat metabolism, and cellular regeneration. Syringes and swabs included. Prescription required.
How to Get Started with IGF-1 LR3 at VitalRx
Select IGF-1 LR3
Add the IGF-1 LR3 5mL vial to your order. Your async provider consult is included and will cover dosing, cycling protocol, and what to expect.
Complete Your Async Consult
Answer a brief health intake questionnaire at your own pace — no video call, no waiting room. A licensed provider reviews your submission, screens for contraindications, and issues your prescription when clinically appropriate.
Receive Your Order
Your prescription is filled by Optimal Balance Pharmacy and shipped via FedEx Standard Overnight directly to your door — with syringes and alcohol swabs included.
Prescription required. Async provider visit included. All compounds prepared by Optimal Balance Pharmacy.
Frequently Asked Questions About IGF-1 LR3
The information provided on this page is for educational purposes only and does not constitute medical advice. All medications available through VitalRx require a valid prescription from a licensed healthcare provider. IGF-1 LR3 is not appropriate for patients with active malignancy, diabetic retinopathy, or uncontrolled diabetes. IGF-1 receptor activation may promote the growth of existing cancer cells. Results vary based on individual health status, dosing, cycling protocol, and adherence. This content has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new treatment.